NCT07148999View on ClinicalTrials.gov

An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

September 23, 2025

Primary Completion Date

February 15, 2026

Study Completion Date

February 15, 2026

Conditions

Infertility (IVF Patients)

Interventions

COMBINATION_PRODUCT

Opt-IVF

Opt-IVF provides optimized dosage profile for each patient

OTHER

Control

Physicians will decide the dosage for each day for patients

Trial Locations (2)

77054

RECRUITING

Positivf Fertility, Houston

78249

RECRUITING

Positivf Fertility, San Antonio

All Listed Sponsors

collaborator

IVF Academy of USA

UNKNOWN

collaborator

Positivf Fertility

UNKNOWN

lead

Urmila DIwekar

INDUSTRY

NCT07148999 - An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera | Biotech Hunter | Biotech Hunter